VW says expects to be profitable in 2020 as first-quarter earnings drop
April 29, 2020UK’s Next bolsters finances after coronavirus triggers 41% sales fall
April 29, 2020Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales
at
Novartis on Wednesday won a new European approval for its inflammation drug Cosentyx in a form of arthritis, as the Swiss drugmaker predicts broadening use of its top-selling medicine will eventually push annual sales beyond $5 billion.
Powered by WPeMatico
